$FRANK Catalyst Posts
April 20, 2026Single-day social intelligence recap and verified catalyst posts · ← Back to $FRANK Profile · Market Rankings
💬 Curated Viral Posts & Community Evidence
1 source posts analyzed· 2026-04-20T12:05:10.198209+00:00AstraZeneca (AZN) Stock: Tozorakimab Achieves Phase III COPD Success in MIRANDA Study TLDR Tozorakimab achieved its primary goal in AstraZeneca’s Phase III MIRANDA study for chronic obstructive pulmonary disease The investigational therapy demonstrated significant reduction in